An Evaluation of Concordance of Smartwatch ECG and One Clinical ECG and Comparison of The Two ECGS in Terms of Predictive Risks

St. Jude Children's Research Hospital

Status: Active, not recruiting

Conditions: Childhood Cancer; Cardiomyopathy, Primary

Study type: Observational

Funder types: Other

Identifiers

NCT05617391

WATCH4ECG

Details and patient eligibility

About

The participant is being asked to take part in this trial, because the participant is a survivor of childhood cancer.

Primary Objective

To evaluate remote cardiomyopathy prediction via smartwatch and one clinical ECG and assess the concordance of the two ECGs in terms of predicted risk.

Secondary Objective

To build a novel predictive model solely on smartwatch ECG to predict risk for cardiomyopathy.

Full description

The proposed study is looking to compare the 30 second ECG read from a smartwatch to the clinical ECG during a SJLIFE scheduled ECG appointment.

Enrollment: 1,303 patients

Sex: All

Ages: 22+ years old

Volunteers: No Healthy Volunteers

Inclusion criteria

• SJLIFE participant and 22 years of age or older at time of enrollment
• Participant or legal guardian is able and willing to give informed consent
• At least 5 years after childhood cancer diagnosis

Exclusion criteria

• Been diagnosed with cardiomyopathy on previous SJLIFE ECG
• Currently on heart medication

Trial design

1,303 participants in 1 patient group

Pediatric Childhood Cancer Survivors

Description:

The comparison of two ECGs in terms of predictive risk.